| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |